Level 1. Deviation
PF deflagra Operação Glycon contra comercialização ilegal de dados sensíveis de pacientes do SUS
- Developer
- Not established
- Model
- Not established
- When it happened
- February 4, 2026
- When it was disclosed
- Not established
- How well it is stood up
- Not verified yet
- What caused it
- Not established
- Where it stands now
- Not established
What happened
Reported by gov.br. Listed here with a link to their report. Nobody on this side has checked it against that report, so it carries no level and this is not our account of what happened.
Our assessment
- Actual
- 1 of 5Deviation
- Potential
- 3 of 5Significant control incident
The system behaved contrary to its instructions, and it stayed contained. The potential level is what the behaviour demonstrated here could credibly have led to, judged from the same evidence.
This level rests on news reports. The developer has not confirmed it here.
Why this level
- Sensitive data was reachable. Argues for a potential level of 3
- A security boundary was crossed. Argues for a potential level of 3
- Significant data was exposed. Argues for a potential level of 3
- A safeguard was bypassed. Argues for a potential level of 2
What is established, and what is not
Confirmed
Nothing is confirmed yet.
Reported, not confirmed
A safeguard was bypassed. A claim, so it counts toward potential only
The failure occurred due to weaknesses in access control and authentication; the system allowed unauthorized queries using identifying data to retrieve patient information, bypassing protections meant to safeguard privacy.
Brazilian firm allegedly used AI to illegally resell SUS patient dataA security boundary was crossed. A claim, so it counts toward potential only
The company allegedly used an AI-powered tool designed for health professionals to gain unauthorized access to clinical records.
Brazilian firm allegedly used AI to illegally resell SUS patient dataSensitive data was reachable
In February 2026, the Brazilian Federal Police launched Operation Glycon to dismantle a business structure illegally commercializing sensitive health data from the Unified Health System (SUS).
Brazilian firm allegedly used AI to illegally resell SUS patient dataSignificant data was exposed. A claim, so it counts toward potential only
The system allowed unauthorized access to confidential clinical information of patients through queries using identifying data.
Brazilian firm allegedly used AI to illegally resell SUS patient data
Checked, and did not happen
Nothing here was checked and ruled out.
Not confirmed
Nothing is outstanding.
Where this came from
The original report · read October 2, 2026
PF deflagra Operação Glycon contra comercialização ilegal de dados sensíveis de pacientes do SUSA structured incident database · read September 19, 2026
AI Failure Index (CC-BY-4.0 data fields)Where we first saw it
Brazilian firm allegedly used AI to illegally resell SUS patient dataWhere we first saw it
Empresa alvo de operação usou IA para vender dados de pacientes do SUS
The reports above are other people’s. The levels are ours, worked out under our published rules. No organisation that reported this assigned our number, and none of it is legal advice.
Something here is wrong? Tell us. Send us a source we can open, and a person will read it.